Drug disposition in obesity: toward evidence-based dosing

CAJ Knibbe, MJE Brill, A van Rongen… - Annual review of …, 2015 - annualreviews.org
Obesity and morbid obesity are associated with many physiological changes affecting
pharmacokinetics, such as increased blood volume, cardiac output, splanchnic blood flow …

Drug disposition in obesity: toward evidence-based dosing.

CA Knibbe, MJ Brill, A van Rongen… - Annual Review of …, 2014 - europepmc.org
Obesity and morbid obesity are associated with many physiological changes affecting
pharmacokinetics, such as increased blood volume, cardiac output, splanchnic blood flow …

Drug disposition in obesity: toward evidence-based dosing

CAJ Knibbe, MJE Brill… - Annual review of …, 2015 - pubmed.ncbi.nlm.nih.gov
Obesity and morbid obesity are associated with many physiological changes affecting
pharmacokinetics, such as increased blood volume, cardiac output, splanchnic blood flow …

Drug disposition in obesity: toward evidence-based dosing

CA Knibbe, MJ Brill, A Van Rongen… - 2014 - scholarlypublications …
Obesity and morbid obesity are associated with many physiological changes affecting
pharmacokinetics, such as increased blood volume, cardiac output, splanchnic blood flow …

Drug disposition in obesity: toward evidence-based dosing.

CAJ Knibbe, MJE Brill, A Rongen, J Diepstraten… - 2015 - cabidigitallibrary.org
Obesity and morbid obesity are associated with many physiological changes affecting
pharmacokinetics, such as increased blood volume, cardiac output, splanchnic blood flow …